Log in
OTCMKTS:BSTG

Biostage News Headlines

$1.51
-0.22 (-12.72 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$1.51
Now: $1.51
$1.70
50-Day Range
$1.17
MA: $1.75
$2.89
52-Week Range
$0.80
Now: $1.51
$4.88
Volume678 shs
Average Volume4,097 shs
Market Capitalization$13.70 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.29

Headlines

Biostage (OTCMKTS BSTG) News Headlines Today

Source:
DateHeadline
Soliton (NASDAQ:SOLY) versus Biostage (NASDAQ:BSTG) Critical ComparisonSoliton (NASDAQ:SOLY) versus Biostage (NASDAQ:BSTG) Critical Comparison
americanbankingnews.com - September 7 at 2:39 PM
Biostage Reports Second Quarter 2020 Financial ResultsBiostage Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 13 at 11:52 PM
Biostage Inc.Biostage Inc.
www.marketwatch.com - July 4 at 12:52 AM
Biostage Reports First Quarter 2020 Financial ResultsBiostage Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 14 at 7:59 PM
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of DirectorsMr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
www.bloomberg.com - April 25 at 12:53 AM
Biostage Reports 2019 Financial ResultsBiostage Reports 2019 Financial Results
finance.yahoo.com - March 27 at 6:23 PM
FDA OKs Biostages IND for Cellspan Esophageal ImplantFDA OKs Biostage's IND for Cellspan Esophageal Implant
seekingalpha.com - March 20 at 8:21 AM
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal ImplantBiostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal Implant
finance.yahoo.com - March 20 at 8:21 AM
Biostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal ImplantBiostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
finance.yahoo.com - February 20 at 7:12 PM
Biostage Reports 2018 First Quarter Financial ResultsBiostage Reports 2018 First Quarter Financial Results
www.bloomberg.com - February 18 at 6:40 PM
Biostage Provides Update on FDA Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal ImplantBiostage Provides Update on FDA Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
finance.yahoo.com - January 2 at 9:01 PM
Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal ImplantsBiostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants
finance.yahoo.com - November 25 at 3:34 PM
Biostage Reports Third Quarter 2019 Financial ResultsBiostage Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 12 at 8:12 AM
­­Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Business Update­­Biostage to Host Conference Call to Discuss Third Quarter 2019 Financial Results and Business Update
finance.yahoo.com - November 6 at 8:21 PM
Biostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan™ Esophageal Implant for Treatment of Esophageal ConditionsBiostage Submits Investigational New Drug (IND) Application for Lead Product Candidate Cellspan™ Esophageal Implant for Treatment of Esophageal Conditions
finance.yahoo.com - October 30 at 8:23 AM
Biostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA ApplicationBiostage, Inc. Joins the Stock Day Podcast to Discuss Their Pending FDA Application
finance.yahoo.com - September 3 at 12:42 PM
Biostage, Inc. (BSTG) CEO Jim McGorry on Q2 2019 Results - Earnings Call TranscriptBiostage, Inc. (BSTG) CEO Jim McGorry on Q2 2019 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 4:09 PM
Biostage to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Business UpdateBiostage to Host Conference Call to Discuss Second Quarter 2019 Financial Results and Business Update
finance.yahoo.com - August 7 at 6:24 PM
Biostage, Inc. (BSTG) CEO Jim McGorry on Q1 2019 Results - Earnings Call TranscriptBiostage, Inc. (BSTG) CEO Jim McGorry on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 12:18 PM
Biostage Inc (BSTG) CEO Jim McGorry on Q4 2018 Results - Earnings Call TranscriptBiostage Inc (BSTG) CEO Jim McGorry on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 28 at 4:03 PM
Biostage to Host Conference Call to Discuss 2018 Financial Results and Business UpdateBiostage to Host Conference Call to Discuss 2018 Financial Results and Business Update
finance.yahoo.com - March 22 at 12:11 PM
This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.